Pharmaceutical Drug Targets and Diseases
From Proteopedia
m (→Digetsive Diseases) |
|||
| Line 57: | Line 57: | ||
[[Cyclooxygenase]]<br /> | [[Cyclooxygenase]]<br /> | ||
| - | ==Schizophrenia, Bipolar Depression, Insomnia, and | + | ==Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders== |
[[Dopamine Receptor]]<br /> | [[Dopamine Receptor]]<br /> | ||
[[Andrenergic Receptor]]<br /> | [[Andrenergic Receptor]]<br /> | ||
[[Histamine Receptor]]<br /> | [[Histamine Receptor]]<br /> | ||
[[Opioid Receptor]]<br /> | [[Opioid Receptor]]<br /> | ||
Revision as of 08:02, 17 September 2010
The following is a list of major phamerceutical compound targets, organized by disease.
Alzheimer’s Disease
Acetylcholinesterase
Amyloid Beta
Gamma-Secratase
Glutamate receptor (GluA2)
Anemia
Asthma and other Pulmonary Disease States
Beta-2-Andrenergic Receptor
Leukotriene Receptor
Autoimmune Diseases
Tumor Necrosis Factor Receptor
Blood Clots & Thrombic Events
Cancer
Epidermal Growth Factor & Epidermal Growth Factor Receptor
Human Epidermal Growth Factor Receptor 2
p53
Phosphatidylinositol 3-Kinase
Tyrosine Kinase
Vascular Endothelial Growth Factor & Vascular Endothelial Growth Factor Receptor
Compromised Immune System
Granulocyte-macrophage colony-stimulating factor
Diabetes & Hypoglycemia
Peroxisome Proliferator-Activated Receptors
Digestive Diseases
Erectile Dysfunction
cGMP-Specific Phosphodiesterase Type 5
HIV
Hypercholesterolemia (Elevated Cholesterol)
Hypertension & Congestive Heart Failure
Angiotensin-Converting Enzyme
Calcium Channel
Inflammation & Rheumatoid Arthritis
Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders
Dopamine Receptor
Andrenergic Receptor
Histamine Receptor
Opioid Receptor
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
